Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC

SIMPLE SUMMARY: Hepatocellular carcinoma is an aggressive cancer with high mortality. The introduction of immune-checkpoint inhibitors (ICIs) targeting the programmed-cell death 1 pathway (PD-1/L1) has led to a paradigmatic change in the systemic treatment of HCC. However, the important challenges o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Dong, Yawen, Wong, Jeffrey Sum Lung, Sugimura, Ryohichi, Lam, Ka-On, Li, Bryan, Kwok, Gerry Gin Wai, Leung, Roland, Chiu, Joanne Wing Yan, Cheung, Tan To, Yau, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8072916/
https://ncbi.nlm.nih.gov/pubmed/33919570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13081949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados